about
In vitro and in vivo activities of ruthenium(II) phosphine/diimine/picolinate complexes (SCAR) against Mycobacterium tuberculosisFirst baseline of circulating genotypic lineages of Mycobacterium tuberculosis in patients from the brazilian borders with Argentina and ParaguayEssential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida SpeciesNew antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016).Evaluation of the anti-mycobacterium tuberculosis activity and in vivo acute toxicity of Annona sylvatic.Opportunistic pathogens and elements of the resistome that are common in bottled mineral water support the need for continuous surveillance.Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium spSynthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis.Systematic review on the proteomic profile of Mycobacterium tuberculosis exposed to drugs.Cell-Envelope Remodeling as a Determinant of Phenotypic Antibacterial Tolerance in Mycobacterium tuberculosis.In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.Novel Zinc(II) Complexes [Zn(atc-Et)₂] and [Zn(atc-Ph)₂]: In Vitro and in Vivo Antiproliferative Studies.Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosisCurrent Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets.Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.Bis(diphenylphosphino)amines-containing ruthenium cymene complexes as potential anti-Mycobacterium tuberculosis agents.Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities.Pre-Multidrug-Resistant Mycobacterium tuberculosis Infection Causing Fatal Enteric Disease in a Dog from a Family with History of Human Tuberculosis.Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): X-ray structure of trans-[Pd(N3)2(isn)(2)].Design of novel iron compounds as potential therapeutic agents against tuberculosis.Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.Antitumor and antimycobacterial activities of cyclopalladated complexes: X-ray structure of [Pd(C2,N-dmba)(Br)(tu)] (dmba=N,N-dimethylbenzylamine, tu=thiourea).Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.In vitro evaluation of the cyto-genotoxic potential of Ruthenium(II) SCAR complexes: a promising class of antituberculosis agents.Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.Evaluation of cytotoxic, apoptotic, mutagenic, and chemopreventive activities of semi-synthetic esters of gallic acid.Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle.Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group.Aromatic amine N-oxide organometallic compounds: searching for prospective agents against infectious diseases.Antitubercular activity of Ru (II) isoniazid complexes.Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity.Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity.Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents.Synthesis and evaluation of a pyrazinoic acid prodrug in Mycobacterium tuberculosisChemical composition and antioxidant and antimycobacterial activities of Bromelia balansae (Bromeliaceae).
P50
Q28533382-DD40B217-B4D4-49FF-BC97-87236E0DB2ECQ28542896-F73C9B90-504B-42E6-92BC-32137D5B9423Q28828813-B23D8378-95E0-4546-9FA8-C72D074F3A77Q30243915-9BBA00DA-678C-49E2-B74B-D352E535A964Q33849036-460B1F87-508E-4408-92DD-905B304EB759Q35585480-7F5FBA83-1F10-4AA9-BF62-751114D15525Q35954636-CBC64956-0BB1-4D2B-BAE8-068D3AF8CDC5Q36236855-CDAEF161-DAEF-457C-ACC8-9DDC0BEE1494Q36408943-A5BCF666-F0D3-40D2-B0E9-2297CB58CB6CQ36927203-F0979E12-CB5B-4D34-B0BA-6D07790F1F53Q36939307-0C4950AB-DE23-4F1B-AAA3-F2A2DFF5F002Q36939375-9C863756-FB9A-4D42-A7C0-9075670A9770Q37722890-8760EEF5-0597-4B86-AB06-251422A31A64Q38568643-7124D028-674F-451F-B15C-21942F5FAC44Q38705222-EBB3C23A-3452-48C2-AE47-780835426D9DQ38752726-3D17AE4B-17D1-4D74-8E24-EC00AC953ADBQ38759540-259D5D12-DA66-4181-8C1D-1E28864E247EQ38776845-469DC296-AC69-45F2-AAE8-186D84BF59BEQ38898800-92E3DAD3-5AC8-4EB8-A6BD-3675BB0DCB29Q38956108-51DD86AB-276D-40D5-8110-BFA25895B4D9Q39482623-B79D2051-02A1-4D37-BF56-4CADA05A9DEFQ39503683-9BA81446-5455-4782-8637-6CFA30EA78C5Q39644461-2375038F-1E9A-409D-88ED-8BECCF61F3B5Q39665549-A83EA4C0-07E2-45E9-A5E0-2BA28B8AB375Q39668616-8487DDA9-2CAC-400A-8937-5F872E2E0FDEQ39738194-B5B49E33-CFB9-4E9B-94E0-811B96BD69BDQ39820844-1F3CB2F9-5A31-440A-8450-4765EDF270F3Q39854453-47E693F1-4D38-4606-9182-71F905C8F9D1Q39905373-E2354333-EA03-45CB-A138-BBD331D1A445Q39963347-F7788731-54C8-488F-B217-1D0B276BAA36Q40222640-6A3D8FCA-03D9-46F2-87DD-3D309D8ED568Q40233427-ABF40D11-697A-473B-8CEA-6AD93F6F12F1Q40678521-EA46109C-A12C-4D44-9703-8D05888ACC75Q41093486-6525B162-021A-40AA-A212-44D51A8EFC90Q41501293-F3A06370-E0F7-48E0-947F-57B66AACEF5BQ41844196-406FD854-1677-486A-B910-221A3D1E2A93Q41992338-2245CEBA-803A-4F72-8BEF-E24B8E6C0D3DQ42708596-BDD35D43-BF0E-46C1-A186-E28845B63B3DQ42836733-00211918-A743-479D-B163-1F18E9CF6DB6Q42931158-D4021BA8-1022-46A8-A3B1-EA030E3CC2C1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fernando R Pavan
@es
Fernando R Pavan
@nl
Fernando R Pavan
@sl
Fernando R. Pavan
@en
type
label
Fernando R Pavan
@es
Fernando R Pavan
@nl
Fernando R Pavan
@sl
Fernando R. Pavan
@en
prefLabel
Fernando R Pavan
@es
Fernando R Pavan
@nl
Fernando R Pavan
@sl
Fernando R. Pavan
@en
P1053
F-6046-2010
P106
P1153
24449695800
P21
P2798
P31
P3829
P496
0000-0002-6969-3963